Cargando…
Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome
COVID-19 patients can present with pulmonary edema early in disease. We propose that this is due to a local vascular problem because of activation of bradykinin 1 receptor (B1R) and B2R on endothelial cells in the lungs. SARS-CoV-2 enters the cell via ACE2 that next to its role in RAAS is needed to...
Autores principales: | van de Veerdonk, Frank L, Netea, Mihai G, van Deuren, Marcel, van der Meer, Jos WM, de Mast, Quirijn, Brüggemann, Roger J, van der Hoeven, Hans |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213974/ https://www.ncbi.nlm.nih.gov/pubmed/32338605 http://dx.doi.org/10.7554/eLife.57555 |
Ejemplares similares
-
Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19
por: van de Veerdonk, Frank L., et al.
Publicado: (2020) -
Blockade of the kallikrein-kinin system reduces endothelial complement activation in vascular inflammation
por: Lopatko Fagerström, Ingrid, et al.
Publicado: (2019) -
Ebola Virus Disease has Features of Hemophagocytic Lymphohistiocytosis Syndrome
por: van der Ven, Andre J. A. M., et al.
Publicado: (2015) -
The kallikrein-kinin system in diabetic nephropathy
por: Tomita, Hirofumi, et al.
Publicado: (2012) -
Kallikrein–kinin system: is it the fountain of youth?
por: Garaffa, Giulio, et al.
Publicado: (2017)